The UK government is taking a fresh look at gambling. A white paper, expected in spring 2022, will […]

The image of Queen Elizabeth II sitting alone in a black facemask at the funeral of her husband […]

As hospitals in the US and elsewhere fill again with patients with covid-19, discussions about how to fairly […]

Market authorisation for twice yearly schizophrenia treatment which offers patients much-needed medication continuity

Ayvakyt receives a positive opinion from the CHMP for the treatment of adults with advanced systemic mastocytosis

CMS’ Biogen decision could spell problems for Lilly, Roche Alzheimer’s drugs, half of surveyed neurologists say badams Tue, […]

AstraZeneca runs first kidney disease focused Farxiga TV ad, getting in the homes of 37M people with this […]

Biogen’s Aduhelm support campaign backfires as CMS receives many more comments in favor of restrictive coverage: analyst fkansteiner […]

Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig esagonowsky Tue, 02/01/2022 – 10:36

Novartis’ Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone fkansteiner Tue, 02/01/2022 – 11:09